Cannabis Abuse Clinical Trial
Official title:
COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE
General objective:
To assess the effectiveness of a treatment program specific for cannabis abuse (cognitive
behavioral treatment + pharmacological treatment) compared to standard treatment
(pharmacological treatment + psychoeducation) in patients with first episodes psychosis (FEP)
cannabis users.
Design A multicenter single-blind randomized study with 1 year of follow-up. The
effectiveness of a treatment program specific for cannabis abuse (cognitive behavioral
treatment + pharmacological treatment) compared to standard treatment (pharmacological
treatment + psychoeducation) in patients with first episodes psychosis (FEP) cannabis users
will be assessed.
Patients will be randomly assigned to one of two treatments:
1. Experimental group (N=50): Cognitive-behavioral treatment specific for cannabis abuse +
pharmacological treatment
2. Control group (N=50): standard treatment: psychoeducation + pharmacological treatment
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00687609 -
Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
|
Phase 4 | |
| Completed |
NCT00350285 -
The Teen Marijuana Check-Up
|
Phase 2 | |
| Completed |
NCT00149643 -
Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
|
Phase 2 | |
| Completed |
NCT00108407 -
Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse
|
N/A | |
| Completed |
NCT00498550 -
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
|
Phase 4 | |
| Completed |
NCT01603992 -
Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms
|
||
| Completed |
NCT01037608 -
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
|
Phase 1 | |
| Completed |
NCT01639872 -
Clozapine for Cannabis Use in Schizophrenia
|
Phase 4 | |
| Not yet recruiting |
NCT06395688 -
Drug-Drug Interaction Between THC and AEF0117
|
Phase 1 | |
| Completed |
NCT01875796 -
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
|
Phase 1 | |
| Recruiting |
NCT05833230 -
Investigating Real-world Stress-related Mechanisms in Heavy Cannabis Users
|
N/A | |
| Active, not recruiting |
NCT00484367 -
A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT06249542 -
Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment
|
N/A | |
| Withdrawn |
NCT01784627 -
Trial of Computerized SBI to Reduce Teen Alcohol Use
|
Phase 1 | |
| Recruiting |
NCT05219825 -
Breathwork-assisted Treatment for Cannabis Use Disorder
|
N/A | |
| Terminated |
NCT01439828 -
Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal
|
Phase 2 | |
| Completed |
NCT00376233 -
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia
|
N/A | |
| Completed |
NCT01110434 -
Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents
|
Phase 2 | |
| Completed |
NCT01204723 -
Medications Development for the Treatment of Cannabis Related Disorders
|
Phase 1 |